Previous close | 44.00 |
Open | 44.00 |
Bid | 45.70 |
Ask | 48.90 |
Strike | 640.00 |
Expiry date | 2024-12-20 |
Day's range | 44.00 - 44.00 |
Contract range | N/A |
Volume | |
Open interest | 46 |
Myriad Genetics and Ultima Genomics to explore the latter's sequencing platform for advanced clinical tests in oncology and reproductive genomics.
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
(Bloomberg) -- Paul Parker, a former mergers and acquisitions banker turned health-care executive, is joining Flagship Pioneering Inc., the investment firm that created Covid-vaccine maker Moderna Inc.Most Read from BloombergUrban Heat Stress Is Another Disparity in the World’s Most Unequal NationChicago’s $1 Billion Budget Hole Exacerbated by School TurmoilShould Evictions Be Banned After Hurricanes and Climate Disasters?From Cleveland to Chicago, NFL Teams Dream of Domed StadiumsSingapore Ends